Respiratory Syncytial Virus News and Research

RSS

Ebola virus forms "viral factories" to replicate inside host cells

New research in the journal Nature Communications gives scientists an important window into how Ebola virus replicates inside host cells.

9 Aug 2023

RSV vaccine recommendation rates increase when people are informed about FDA approval process

A new study finds that people are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from RSV illness if they are shown a chart outlining the rigorous process a vaccine undergoes to be approved by the Food and Drug Administration (FDA).

9 Aug 2023

Covid cases and hospital admissions soar, leading testing expert warns of resurgence

A leading testing expert fears the UK is facing a Covid resurgence, as cases and hospital admissions soar. He says the Government must resume the antibody testing program it scrapped in March.

7 Aug 2023

The immunomodulatory and antiviral function of vitamin D

Vitamin D's immunomodulatory and antiviral function.

4 Aug 2023

Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Researchers describe the symptom profiles of respiratory viral infections.

4 Aug 2023

Point-of-care rapid diagnostics for detecting SARS-CoV-2 in exhaled breath

Researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of SARS-CoV-2 in exhaled breath.

3 Aug 2023

Survey highlights substantial gaps in knowledge about maternal health

Most people know it isn't safe to smoke or drink alcohol while pregnant, and most know that how well a pregnant person takes care of their health affects the health of their baby.

1 Aug 2023

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

Flu and COVID-19 report offers latest surveillance data and public health advice

This fortnightly flu and COVID-19 report brings together the latest surveillance data along with the latest public health advice.

21 Jul 2023

RSV vaccines: A long-awaited breakthrough

Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update on RSV vaccine research.

20 Jul 2023

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

The Health Protection Notification Regulations 2010 (HPNR) help us respond promptly to suspected cases of infectious disease that could have an impact on public health.

13 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

7DW8-5, a glycolipid that utilizes the body's non-specific immune response to quickly combat viral infections, including COVID-19 in vivo.

11 Jul 2023

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses.

10 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

Multiple drug targets for the treatment of influenza identified using AI program

Poolbeg Pharma, a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, announces a significant breakthrough in its world first influenza Artificial Intelligence ('AI') Programme with CytoReason.

1 Jul 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Investigating Human metapneumovirus (HMPV) prevalence, genetic diversity, and evolution in respiratory tract infections (RTIs) for better understanding and management.

31 May 2023

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Researchers investigated the prevalence of human metapneumovirus through 2020 considering the implementation of NPIs due to the COVID-19 pandemic.

31 May 2023

Respiratory Syncytial Virus News and Research

Ebola virus forms "viral factories" to replicate inside host cells

RSV vaccine recommendation rates increase when people are informed about FDA approval process

Covid cases and hospital admissions soar, leading testing expert warns of resurgence

The immunomodulatory and antiviral function of vitamin D

Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Point-of-care rapid diagnostics for detecting SARS-CoV-2 in exhaled breath

Survey highlights substantial gaps in knowledge about maternal health

RSV vaccines for older adults: 2023 ACIP recommendations

New device can detect COVID-19 in less than a minute

Flu and COVID-19 report offers latest surveillance data and public health advice

RSV vaccines: A long-awaited breakthrough

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

A novel RSV vaccine that could be effective across all ages

Multiple drug targets for the treatment of influenza identified using AI program

Battle against RSV: Computational design paves way for new polyvalent vaccine

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News